ELMHURST BLOODSTOCK LIMITED

ELMHURST BLOODSTOCK LIMITED

ELMHURST BLOODSTOCK LIMITED - Company Information

Print Friendly Version

ELMHURST BLOODSTOCK LIMITED

Company Registration Number:
02097703 (England and Wales)

Unaudited abridged accounts for the year ended 30 September 2022

Period of accounts

Start date: 01 October 2021

End date: 30 September 2022

ELMHURST BLOODSTOCK LIMITED

Contents of the Financial Statements

for the Period Ended 30 September 2022

Balance sheet
Notes

ELMHURST BLOODSTOCK LIMITED

Balance sheet

As at 30 September 2022


Notes
2022
2021


£
£
Fixed assets
Tangible assets: 3 993 1,242
Total fixed assets: 993 1,242
Current assets
Stocks: 0 14,405
Debtors:   26,663 2,199
Cash at bank and in hand: 0 6,158
Total current assets: 26,663 22,762
Creditors: amounts falling due within one year: 4 (16,849) (8,484)
Net current assets (liabilities): 9,814 14,278
Total assets less current liabilities: 10,807 15,520
Provision for liabilities: (180) (225)
Total net assets (liabilities): 10,627 15,295
Capital and reserves
Called up share capital: 10,000 10,000
Profit and loss account: 627 5,295
Shareholders funds: 10,627 15,295

The notes form part of these financial statements

ELMHURST BLOODSTOCK LIMITED

Balance sheet statements

For the year ending 30 September 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 30 May 2023
and signed on behalf of the board by:

Name: J NEEDHAM
Status: Director

The notes form part of these financial statements

ELMHURST BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2022

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover represents the value of sales and commissions earned in the year net of Value Added Tax and is recognised at the point of sale or by reference to the stage of completion of the service at the balance sheet date.

Tangible fixed assets and depreciation policy

Tangible fixed assets are stated at cost less accumulated depreciation and impairment losses. Depreciation is calculated to write off the cost of tangible fixed assets over their estimated useful lives to the Business.The annual depreciation rates and methods are as follows;-Office Equipment-20% reducing instalments method.

Valuation and information policy

Biological Stock is shown at fair value, being market price for the asset based on current expectations less costs and selling expenses.

Other accounting policies

Taxation:Taxation represents the sum of tax currently payable and deferred tax. Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.Debtors and Creditors Receivable/Payable Within One Year:Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in administrative expenses.

ELMHURST BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2022

2. Employees

2022 2021
Average number of employees during the period 2 2

ELMHURST BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2022

3. Tangible Assets

Total
Cost £
At 01 October 2021 10,223
At 30 September 2022 10,223
Depreciation
At 01 October 2021 8,981
Charge for year 249
At 30 September 2022 9,230
Net book value
At 30 September 2022 993
At 30 September 2021 1,242

ELMHURST BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2022

4. Creditors: amounts falling due within one year note

There are no secured creditors.

ELMHURST BLOODSTOCK LIMITED

Notes to the Financial Statements

for the Period Ended 30 September 2022

5. Related party transactions

Name of the related party: J Needham
Relationship:
Director
Description of the Transaction: J Needham has provided a guarantee in the sum of £10,000 (2021:£10,000 ) to the Company's bankers in respect of borrowing facilities made available to the Company.
£
Balance at 01 October 2021 10,000
Balance at 30 September 2022 10,000